We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$51.1B
AUM Growth
+$2.09B
(+4.3%)
Cap. Flow
-$1.46B
Cap. Flow
% of AUM
-2.85%
Top 10 Holdings %
Top 10 Hldgs %
22.51%
Holding
1,173
New
222
Increased
229
Reduced
441
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XEC
CIMAREX ENERGY CO
XEC
|
+$190M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$171M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$139M |
| 4 |
Textron
TXT
|
+$133M |
| 5 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$325M |
| 2 |
EOG Resources
EOG
|
+$245M |
| 3 |
Honeywell
HON
|
+$186M |
| 4 |
Merck
MRK
|
+$149M |
| 5 |
Kohl's
KSS
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.75% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 14.77% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Communication Services | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
NiSource
NI
$21.3B
| $10.4M | 0.02% |
426,362
-684,200
| -62% | -$17.4M |
|
677
Dentsply Sirona
XRAY
$2.86B
| $10.3M | 0.02% |
162,600
+119,300
| +276% | +$7.86M |
|
678
Prothena Corp
PRTA
$444M
| $10.3M | 0.02% |
+200,000
| New | +$6.24M |
|
|
OMEG
679
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
| $10.3M | 0.02% |
1,030,770
| – | – |
|
680
Invesco
IVZ
$14.1B
| $10.3M | 0.02% |
383,569
-9,900
| -3% | -$270K |
|
681
Quest Diagnostics
DGX
$25.8B
| $10.2M | 0.02% |
77,300
+31,600
| +69% | +$4.14M |
|
682
GH Research
GHRS
$2B
| $10.1M | 0.02% |
+465,000
| New | +$9.5M |
|
683
Affirm
AFRM
$26.2B
| $10.1M | 0.02% |
150,000
+75,000
| +100% | +$4.78M |
|
|
CPARU
684
DELISTED
Catalyst Partners Acquisition Corp. Unit
CPARU
| $10.1M | 0.02% |
+1,000,000
| New | +$10.1M |
|
685
Pinnacle West Capital
PNW
$12.3B
| $10.1M | 0.02% |
+123,183
| New | +$10.4M |
|
686
Baker Hughes
BKR
$61.3B
| $10M | 0.02% |
438,202
-24,000
| -5% | -$554K |
|
687
Expeditors International
EXPD
$23.7B
| $10M | 0.02% |
79,000
-24,400
| -24% | -$2.88M |
|
688
WEC Energy
WEC
$35.6B
| $10M | 0.02% |
+112,408
| New | +$10.6M |
|
689
Kimberly-Clark
KMB
$37B
| $9.98M | 0.02% |
+74,633
| New | +$9.96M |
|
|
PRDS
690
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $9.98M | 0.02% |
1,000,000
| – | – |
|
|
FPAC
691
DELISTED
Far Peak Acquisition Corporation
FPAC
| $9.95M | 0.02% |
1,000,000
| – | – |
|
692
DaVita
DVA
$14.6B
| $9.92M | 0.02% |
82,400
-1,800
| -2% | -$213K |
|
|
AUS
693
DELISTED
Austerlitz Acquisition Corporation I
AUS
| $9.92M | 0.02% |
+1,000,000
| New | +$9.92M |
|
694
Ulta Beauty
ULTA
$23.4B
| $9.89M | 0.02% |
28,600
-33,795
| -54% | -$11.1M |
|
695
Kilroy Realty
KRC
$4.58B
| $9.89M | 0.02% |
141,979
+33,674
| +31% | +$2.33M |
|
|
FVT
696
DELISTED
Fortress Value Acquisition Corp. III
FVT
| $9.82M | 0.02% |
1,000,000
| – | – |
|
|
JNPR
697
DELISTED
Juniper Networks
JNPR
| $9.81M | 0.02% |
358,800
+143,900
| +67% | +$3.83M |
|
|
LOKM
698
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
| $9.8M | 0.02% |
+1,000,000
| New | +$9.78M |
|
|
AVEO
699
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $9.76M | 0.02% |
1,481,000
+517,000
| +54% | +$3.56M |
|
700
Madrigal Pharmaceuticals
MDGL
$11.7B
| $9.74M | 0.02% |
100,000
+37,677
| +60% | +$4.46M |
|
Similar funds
Adage Capital Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Adage Capital Partners held 1,173 positions worth $51.1B, up 4.3% from $49B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Adage Capital Partners's Q2 2021 filing shows 222 new, 229 increased, 441 reduced and 163 closed positions. Its largest new stake was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M. The largest sale was GW Pharmaceuticals Plc American Depositary Shares, an estimated $325M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q2 2021 buy was Royal Dutch Shell PLC ADS Class A: 3,150,000 shares worth $127M.
- Adage Capital Partners added most to CIMAREX ENERGY CO in Q2 2021, an estimated $190M increase.
- Adage Capital Partners's biggest Q2 2021 reduction was EOG Resources, cutting an estimated $245M.
- Adage Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $325M.
- Adage Capital Partners's ten largest holdings make up 23% of its $51.1B portfolio in Q2 2021.
- Adage Capital Partners opened 222 new positions and closed 163 in Q2 2021.
- Adage Capital Partners's portfolio value rose 4.3% quarter-over-quarter to $51.1B.
Based on Adage Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.